p16INK4a expression in cytology of ascites and response to chemotherapy in advanced ovarian cancer-Reference-Cited by-同舟云学术

p16INK4a expression in cytology of ascites and response to chemotherapy in advanced ovarian cancer

Published:2009-07-15 Issue:2 Volume:125 Page:339-344
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Goto Tomoko,Takano Masashi,Hirata Junko,Kohno Toshiyuki,Ohtsuka Shigenori,Fujiwara Keiichi,Tsuda Hitoshi

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference31 articles.

1. Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer;Jacob;Gynecol Oncol,1991

2. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients;Vergote;Gynecol Oncol,1998

3. Neoadjuvant chemotherapy or primary surgery in advanced epithelial ovarian carcinoma;Kayikçioglu;Int J Gynecol Cancer,2001

4. Interval debulking surgery: an alternative for primary surgical debulking?;Vergote;Semin Surg Oncol,2000

5. Feasibility study of neoadjuvant chemotherapy (NAC) followed by interval debulking surgery (IDS) for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group study JCOG0206;Onda;J Clin Oncol ASCO Annu Meeting Proc,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA Repair Protein HELQ and XAB2 as Chemoresponse and Prognosis Biomarkers in Ascites Tumor Cells of High-Grade Serous Ovarian Cancer;Journal of Oncology;2022-03-29

2. Ovarian Cancer;Serous Effusions;2018

3. Prognostic significance of several biomarkers in epithelial ovarian cancer: a meta-analysis of published studies;Journal of Cancer Research and Clinical Oncology;2013-04-18

4. Ovarian/Primary Peritoneal Carcinoma;Serous Effusions;2011-10-04

5. New players in ovarian cancer;Journal of Cellular Physiology;2011-07-22